Conmed Corp (CNMD) Misses Q2 EPS by 1c; Guides
Conmed Corp (NASDAQ: CNMD) reported Q2 EPS of $0.43, $0.01 worse than the analyst estimate of $0.44. Revenue for the quarter came in at $193 million versus the consensus estimate of $193.55 million.
Conmed Corp sees FY2013 EPS of $1.80-$1.85, versus prior guidance of $1.80-$1.90 and the consensus of $1.86. Conmed Corp sees FY2013 revenue of $770-775 million, versus prior guidance of $770-780 million.
Conmed Corp sees Q2 2013 EPS of $0.37-$0.42, versus the consensus of $0.42. Conmed Corp sees Q2 2013 revenue of $184-189 million, versus the consensus of $186.3 million.
For earnings history and earnings-related data on Conmed Corp (CNMD) click here.
Conmed Corp sees FY2013 EPS of $1.80-$1.85, versus prior guidance of $1.80-$1.90 and the consensus of $1.86. Conmed Corp sees FY2013 revenue of $770-775 million, versus prior guidance of $770-780 million.
Conmed Corp sees Q2 2013 EPS of $0.37-$0.42, versus the consensus of $0.42. Conmed Corp sees Q2 2013 revenue of $184-189 million, versus the consensus of $186.3 million.
For earnings history and earnings-related data on Conmed Corp (CNMD) click here.